Skip to content
DE

Firmicutes

Clinical review pending

Firmicutes make up part of the gut community. What their proportion can tell you, how testing works, and why context matters more than a target percentage.

A woven golden ribbon bridges two islands of paper organic forms.

The evidence comparison is documented; independent clinical review is pending.

A common bacterial group in the gut microbiome

Firmicutes are a large group of bacteria with very different characteristics. In a microbiome report, the Firmicutes value describes their relative share of the bacteria detected in a stool sample. It does not measure overall gut health or the activity of every member of the group.

Laboratories analyze bacterial DNA using methods such as 16S ribosomal RNA gene sequencing or shotgun metagenomics. Databases and analytical methods affect which bacteria are detected and how they are classified. Results from different laboratories are therefore not directly interchangeable. A methods study by Laudadio and colleagues found differences between the two approaches; it did not validate a commercial health test.

What Firmicutes tell us about the gut

Some Firmicutes break down fiber and produce short-chain fatty acids. One of these, butyrate, provides energy for cells lining the colon. Research on these metabolites also explores their role in the gut barrier and immune responses. Those functions help explain why these bacteria interest researchers. A Firmicutes percentage alone, however, does not reveal how much butyrate your gut produces.

Some members of the group are associated with health, others with disease. Combining them into one overall proportion loses much of that detail. The percentage cannot explain bloating, rashes, fatigue or a change in bowel habits. Nor does it provide a reliable personal guide to weight or blood sugar.

Reading the percentage in context

A relative proportion can rise because Firmicutes increase or because other bacteria decrease. The number alone cannot distinguish the two. Comparison with a reference population is also different from comparison with a medically defined normal range.

Some reports add a Firmicutes-to-Bacteroidetes ratio. Studies have produced conflicting results. An analysis by Magne and colleagues argues against treating it as a reliable marker of obesity. The international consensus on microbiome testing discourages reporting the ratio.

High species diversity or the presence of familiar butyrate producers such as Roseburia does not prove that the gut barrier is intact either. These features are useful research subjects, but combining them does not create a universal gut-health score.

Where a Firmicutes test fits into an assessment

With persistent digestive symptoms, finding their cause is more useful than searching for a favorable bacterial ratio. Appropriate investigations depend on symptoms, medical history and clinical findings. Blood tests such as C-reactive protein or fasting glucose have their own medical uses. Combining them with a Firmicutes percentage does not establish a link between gut microbes and inflammation or metabolism.

There is currently insufficient clinical evidence to support routine microbiome profiling for preventive health checks or treatment selection. That also applies during pregnancy. If you already have a report, you can bring it to a medical appointment. The useful discussion is about investigating symptoms and considering the benefits of possible next steps, rather than reaching a particular percentage.

Frequently asked questions

What does a Firmicutes test measure?

It estimates the relative share of this bacterial group in the stool sample. The scope and resolution depend on the method. Bacterial 16S analysis does not detect fungi; shotgun metagenomics can capture additional organisms and genes. Finding a gene does not mean it is active or producing a particular amount of a substance.

How is the sample collected?

Usually, you collect a small stool sample at home in the supplied container. Follow the laboratory’s instructions for collection, labeling, storage and shipping. Avoid contamination and wash your hands afterward. Do not change your usual diet or medicines specifically for this test unless you have agreed to do so with your clinician.

What can my Firmicutes results tell me about my health?

They describe part of the sample’s bacterial composition. They cannot establish whether you absorb nutrients adequately, have inflammation or have an impaired gut barrier. Research on the microbiome and gut–brain communication likewise does not allow conclusions about your mood or concentration from this single value.

How accurate and reliable are Firmicutes tests?

Sequencing can detect bacterial groups, but results depend on collection, DNA preparation, sequencing depth and analysis, among other factors. A technically careful measurement does not automatically answer a clinically useful question. Assessing a particular provider would require its own validation data.

How often should I test Firmicutes?

There is no established testing interval for people without symptoms. A dietary change or probiotic use does not, by itself, justify regular repeat testing. Before another test, it should be clear which medical decision the result could actually change.

Can Firmicutes populations change quickly?

Yes. At least some groups respond to dietary changes. A small controlled dietary study found rapid changes on a strongly animal-based diet, including a reduction in some fiber-degrading Firmicutes. This demonstrates the microbiome’s ability to adapt, but not a benefit from frequent home testing. It does not establish a general waiting period after which the microbiome supposedly becomes stable.

Do Firmicutes results diagnose a condition?

The overall proportion does not diagnose a disease, and an unremarkable report does not rule one out. Targeted medical stool tests, such as tests for particular pathogens or inflammatory markers, answer different questions from a microbiome profile.

What can I do with my Firmicutes result?

Avoid basing a diet or treatment decision on the percentage alone. A low or high proportion does not identify the right probiotic, prebiotic or supplement for you. If you want to change your diet, start with your symptoms, food tolerance and health goals. A qualified dietitian can help when needed, without making a particular Firmicutes value the target.

Sources and further reading

  • Magne F, Gotteland M, Gauthier L, Zazueta A, Pesoa S, Navarrete P, Balamurugan R (2020). The Firmicutes/Bacteroidetes ratio: A relevant marker of gut dysbiosis in obese patients? Nutrients, 12(5), 1474. https://doi.org/10.3390/nu12051474 Source

  • Parada Venegas D, De la Fuente MK, Landskron G, González MJ, Quera R, Dijkstra G, Harmsen HJM, Faber KN, Hermoso MA (2019). Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Frontiers in Immunology, 10, 277. https://doi.org/10.3389/fimmu.2019.00277 Source

  • Afzaal M, Saeed F, Shah YA, Hussain M, Rabail R, Socol CT, Hassoun A, Pateiro M, Lorenzo JM, Rusu AV, Aadil RM (2022). Human gut microbiota in health and disease: Unveiling the relationship. Frontiers in Microbiology, 13, 999001. https://doi.org/10.3389/fmicb.2022.999001 Source

  • Laudadio I, Fulci V, Palone F, Stronati L, Cucchiara S, Carissimi C (2018). Quantitative assessment of shotgun metagenomics and 16S rDNA amplicon sequencing in the study of human gut microbiome. OMICS, 22(4), 248-254. https://doi.org/10.1089/omi.2018.0013 Source

  • Porcari S et al. (2025). International consensus statement on microbiome testing in clinical practice. The Lancet Gastroenterology & Hepatology, 10(2), 154-167. https://doi.org/10.1016/S2468-1253(24)00311-X Source

  • David LA et al. (2014). Diet rapidly and reproducibly alters the human gut microbiome. Nature, 505, 559–563. https://doi.org/10.1038/nature12820 Full text

Source and editorial review status

Adapted for Nutrient Desk from the source article and assessed against the specialist sources listed above. The evidence comparison and its limitations are documented in the article’s review report. Independent clinical review is pending.